These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 30949842)
1. Conversion surgery for initially unresectable pancreatic cancer: current status and unresolved issues. Yoshitomi H; Takano S; Furukawa K; Takayashiki T; Kuboki S; Ohtsuka M Surg Today; 2019 Nov; 49(11):894-906. PubMed ID: 30949842 [TBL] [Abstract][Full Text] [Related]
2. A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer. Cecchini M; Miccio JA; Pahade J; Lacy J; Salem RR; Johnson SB; Blakaj A; Stein S; Kortmansky JS; Johung KL Pancreas; 2020 Aug; 49(7):904-911. PubMed ID: 32658074 [TBL] [Abstract][Full Text] [Related]
3. Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer. Furuse J; Shibahara J; Sugiyama M J Hepatobiliary Pancreat Sci; 2018 May; 25(5):261-268. PubMed ID: 29651809 [TBL] [Abstract][Full Text] [Related]
4. Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience. Nitsche U; Wenzel P; Siveke JT; Braren R; Holzapfel K; Schlitter AM; Stöß C; Kong B; Esposito I; Erkan M; Michalski CW; Friess H; Kleeff J Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1212-20. PubMed ID: 26350368 [TBL] [Abstract][Full Text] [Related]
5. R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial. Fietkau R; Grützmann R; Wittel UA; Croner RS; Jacobasch L; Neumann UP; Reinacher-Schick A; Imhoff D; Boeck S; Keilholz L; Oettle H; Hohenberger WM; Golcher H; Bechstein WO; Uhl W; Pirkl A; Adler W; Semrau S; Rutzner S; Ghadimi M; Lubgan D Strahlenther Onkol; 2021 Jan; 197(1):8-18. PubMed ID: 32914237 [TBL] [Abstract][Full Text] [Related]
6. Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long-Term Chemotherapy. Tsuchiya N; Matsuyama R; Murakami T; Yabushita Y; Sawada Y; Kumamoto T; Endo I World J Surg; 2020 Aug; 44(8):2752-2760. PubMed ID: 32291503 [TBL] [Abstract][Full Text] [Related]
7. Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma with synchronous liver metastasis after treatment with FOLFIRINOX. Ozaki K; Hayashi H; Ikuta Y; Masuda T; Akaboshi S; Ogata K; Matumoto K; Ogawa K; Kamio T; Baba H; Takamori H Clin J Gastroenterol; 2019 Dec; 12(6):603-608. PubMed ID: 30993652 [TBL] [Abstract][Full Text] [Related]
8. A R0 resection case of initially unresectable metastatic pancreatic cancer downstaged by FOLFIRINOX therapy. Sasaki T; Isayama H; Aoki T; Tanaka M; Hamada T; Nakai Y; Sakamoto Y; Hasegawa K; Morikawa T; Fukayama M; Kokudo N; Koike K Pancreas; 2014 Aug; 43(6):972-4. PubMed ID: 25010709 [No Abstract] [Full Text] [Related]
9. Adjuvant surgical therapy for patients with initially-unresectable pancreatic cancer with long-term favorable responses to chemotherapy. Kato K; Kondo S; Hirano S; Tanaka E; Shichinohe T; Tsuchikawa T; Matsumoto J J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):712-6. PubMed ID: 21455748 [TBL] [Abstract][Full Text] [Related]
10. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy. Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P Oncology; 2015; 89(1):37-46. PubMed ID: 25766660 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma. Lind PA; Isaksson B; Almström M; Johnsson A; Albiin N; Byström P; Permert J Acta Oncol; 2008; 47(3):413-20. PubMed ID: 17882555 [TBL] [Abstract][Full Text] [Related]